These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27194382)

  • 1. A common medication for neuropsychiatric illnesses may cause common problems in pregnancy.
    Pennell PB; Meador KJ
    Neurology; 2016 Jun; 86(24):2224-5. PubMed ID: 27194382
    [No Abstract]   [Full Text] [Related]  

  • 2. The safety of calcium channel blockers during pregnancy: a prospective, multicenter, observational study.
    Weber-Schoendorfer C; Hannemann D; Meister R; Eléfant E; Cuppers-Maarschalkerweerd B; Arnon J; Vial T; Rodriguez-Pinilla E; Clementi M; Robert-Gnansia E; De Santis M; Malm H; Dolivo A; Schaefer C
    Reprod Toxicol; 2008 Sep; 26(1):24-30. PubMed ID: 18585452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to mirtazapine during pregnancy: a prospective, comparative study of birth outcomes.
    Djulus J; Koren G; Einarson TR; Wilton L; Shakir S; Diav-Citrin O; Kennedy D; Voyer Lavigne S; De Santis M; Einarson A
    J Clin Psychiatry; 2006 Aug; 67(8):1280-4. PubMed ID: 16965209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of Pregabalin in Pregnancy.
    Andrade C
    J Clin Psychiatry; 2018 Oct; 79(5):. PubMed ID: 30289631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypericum perforatum use during pregnancy and pregnancy outcome.
    Kolding L; Pedersen LH; Henriksen TB; Olsen J; Grzeskowiak LE
    Reprod Toxicol; 2015 Dec; 58():234-7. PubMed ID: 26536653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. North American antiepileptic drug pregnancy registry.
    Holmes LB; Wyszynski DF
    Epilepsia; 2004 Nov; 45(11):1465. PubMed ID: 15509251
    [No Abstract]   [Full Text] [Related]  

  • 7. Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study.
    Diav-Citrin O; Shechtman S; Ornoy S; Arnon J; Schaefer C; Garbis H; Clementi M; Ornoy A
    J Clin Psychiatry; 2005 Mar; 66(3):317-22. PubMed ID: 15766297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pregnancy Outcomes Following In Utero Exposure to Second-Generation Antipsychotics: A Systematic Review and Meta-Analysis.
    Terrana N; Koren G; Pivovarov J; Etwel F; Nulman I
    J Clin Psychopharmacol; 2015 Oct; 35(5):559-65. PubMed ID: 26274044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U.K. epilepsy and pregnancy group.
    Russell AJ; Craig JJ; Morrison P; Irwin B; Waddell R; Parsons L; Robertson I; Guthrie E; Morrow JI
    Epilepsia; 2004 Nov; 45(11):1467. PubMed ID: 15509253
    [No Abstract]   [Full Text] [Related]  

  • 10. Pregnancy outcome of women using atypical antipsychotic drugs: a prospective comparative study.
    McKenna K; Koren G; Tetelbaum M; Wilton L; Shakir S; Diav-Citrin O; Levinson A; Zipursky RB; Einarson A
    J Clin Psychiatry; 2005 Apr; 66(4):444-9; quiz 546. PubMed ID: 15816786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregnancy outcome following maternal exposure to pregabalin may call for concern.
    Winterfeld U; Merlob P; Baud D; Rousson V; Panchaud A; Rothuizen LE; Bernard N; Vial T; Yates LM; Pistelli A; Ellfolk M; Eleftheriou G; de Vries LC; Jonville-Bera AP; Kadioglu M; Biollaz J; Buclin T
    Neurology; 2016 Jun; 86(24):2251-7. PubMed ID: 27194385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
    Diav-Citrin O; Shechtman S; Halberstadt Y; Finkel-Pekarsky V; Wajnberg R; Arnon J; Di Gianantonio E; Clementi M; Ornoy A
    Reprod Toxicol; 2011 May; 31(4):540-5. PubMed ID: 21338666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further analysis of the risk of adverse birth outcome after maternal use of fluoroquinolones.
    Wogelius P; Nørgaard M; Gislum M; Pedersen L; Schønheyder HC; Sørensen HT
    Int J Antimicrob Agents; 2005 Oct; 26(4):323-6. PubMed ID: 16144758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EURAP: an international registry of antiepileptic drugs and pregnancy.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Vajda F;
    Epilepsia; 2004 Nov; 45(11):1463-4. PubMed ID: 15509250
    [No Abstract]   [Full Text] [Related]  

  • 15. Psychotropic medication in pregnancy: The cost-benefit ratio revised.
    Alevizopoulos G
    Psychiatriki; 2015; 26(3):165-8. PubMed ID: 26480220
    [No Abstract]   [Full Text] [Related]  

  • 16. [Problems of psychopharmacological therapy in pregnancy].
    Piccione E
    Clin Ter; 1988 Mar; 124(6):483-7. PubMed ID: 2904847
    [No Abstract]   [Full Text] [Related]  

  • 17. Birth outcomes in pregnant women taking fluoxetine.
    Goldstein DJ; Sundell KL; Corbin LA
    N Engl J Med; 1997 Mar; 336(12):872-3; author reply 873. PubMed ID: 9072683
    [No Abstract]   [Full Text] [Related]  

  • 18. Leflunomide use during pregnancy and the risk of adverse pregnancy outcomes.
    Bérard A; Zhao JP; Shui I; Colilla S
    Ann Rheum Dis; 2018 Apr; 77(4):500-509. PubMed ID: 29222350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychotropic drug use in pregnancy.
    Cohen LS
    Hosp Community Psychiatry; 1989 Jun; 40(6):566-7. PubMed ID: 2661397
    [No Abstract]   [Full Text] [Related]  

  • 20. More on drugs and pregnancy.
    Shader RI; Greenblatt DJ
    J Clin Psychopharmacol; 1995 Feb; 15(1):1-2. PubMed ID: 7714221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.